[HTML][HTML] Prognostic factors for recurrence in pituitary adenomas: recent progress and future directions
L Lu, X Wan, Y Xu, J Chen, K Shu, T Lei - Diagnostics, 2022 - mdpi.com
Pituitary adenomas (PAs) are benign lesions; nonetheless, some PAs exhibit aggressive
behaviors, which lead to recurrence. The impact of pituitary dysfunction, invasion-related …
behaviors, which lead to recurrence. The impact of pituitary dysfunction, invasion-related …
[HTML][HTML] Multidisciplinary management of difficult/aggressive growth-hormone pituitary neuro-endocrine tumors
A Bianchi, S Chiloiro, A Giampietro… - Frontiers in …, 2023 - frontiersin.org
Growth Hormone-secreting adenomas exhibits variable biological behavior and
heterogeneous natural history, ranging from small adenomas and mild disease, to invasive …
heterogeneous natural history, ranging from small adenomas and mild disease, to invasive …
[HTML][HTML] Two Pituitary Neuroendocrine Tumors (PitNETs) with Very High Proliferation and TP53 Mutation — High-Grade PitNET or PitNEC?
W Saeger, C Mawrin, M Meinhardt, AK Wefers… - Endocrine …, 2022 - Springer
We report two pituitary neuroendocrine tumors (PitNETs) with very high Ki67 labeling
indices, many mitoses and TP53 mutation (nearly all tumor cell nuclei were positive for p53) …
indices, many mitoses and TP53 mutation (nearly all tumor cell nuclei were positive for p53) …
[HTML][HTML] Clinical study and systematic review of pituitary microadenomas vs. macroadenomas in Cushing's disease: does size matter?
A Akirov, I Shimon, M Fleseriu, I Dotan… - Journal of Clinical …, 2022 - mdpi.com
Background: Reports on clinical and biochemical differences between adrenocorticotropic
hormone (ACTH)-secreting pituitary microadenomas and macroadenomas are limited and …
hormone (ACTH)-secreting pituitary microadenomas and macroadenomas are limited and …
[HTML][HTML] Radiation therapy for recurrent or residual pituitary macroadenoma invading extrasellar structures
Purpose This study aimed to evaluate the efficacy of radiation therapy (RT) for recurrent or
residual pituitary macroadenoma (PMA) invading extrasellar regions. Materials and Methods …
residual pituitary macroadenoma (PMA) invading extrasellar regions. Materials and Methods …
[HTML][HTML] 垂体ACTH 瘤病理评估研究进展
计铭钰， 杨宇宏， 孙敏 - 南京医科大学学报(自然科学版), 2024 - jnmu.njmu.edu.cn
摘要分泌促肾上腺皮质激素(adrenocorticotropic hormone, ACTH) 的垂体腺瘤(垂体ACTH 瘤)
因过度分泌ACTH 刺激双侧肾上腺皮质增生而引起高皮质醇血症, 也称作库欣病(Cushing's …
因过度分泌ACTH 刺激双侧肾上腺皮质增生而引起高皮质醇血症, 也称作库欣病(Cushing's …
The 2017 WHO classification of pituitary tumors
W Saeger - Der Pathologe, 2021 - Springer
Zusammenfassung Die WHO-Klassifikation der Hypophysentumoren aus dem Jahr 2017
basiert bez. der Adenome weiterhin auf Strukturanalysen und der immunhistologischen …
basiert bez. der Adenome weiterhin auf Strukturanalysen und der immunhistologischen …
[PDF][PDF] TP53 and SF3B1 mutations in pituitary tumours
JF Simon - 2024 - edoc.ub.uni-muenchen.de
The pituitary gland is the master gland of the endocrine system controlling diverse functions,
such as growth, metabolism and reproduction. It is situated in the sella turcica of the …
such as growth, metabolism and reproduction. It is situated in the sella turcica of the …
[引用][C] TP53 and SF3B1 Mutations in Pituitary Tumours: Unravelling Molecular Drivers of Aggressive Tumour Behaviour
JF Simon - 2024 - München, Ludwig-Maximilians …